Cargando…

Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response

BACKGROUND: Acute lung injury (ALI) induces a coagulation/fibrinolysis imbalance and leads to fibrin deposition. The protein C pathway is an important regulator of the coagulation system and reduces the inflammatory response. The aim of the study was to examine the effects of recombinant human activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Robriquet, Laurent, Collet, François, Tournoys, Antoine, Prangère, Thierry, Nevière, Rémi, Fourrier, François, Guery, Benoît P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1435891/
https://www.ncbi.nlm.nih.gov/pubmed/16553944
http://dx.doi.org/10.1186/1465-9921-7-41
_version_ 1782127288098226176
author Robriquet, Laurent
Collet, François
Tournoys, Antoine
Prangère, Thierry
Nevière, Rémi
Fourrier, François
Guery, Benoît P
author_facet Robriquet, Laurent
Collet, François
Tournoys, Antoine
Prangère, Thierry
Nevière, Rémi
Fourrier, François
Guery, Benoît P
author_sort Robriquet, Laurent
collection PubMed
description BACKGROUND: Acute lung injury (ALI) induces a coagulation/fibrinolysis imbalance and leads to fibrin deposition. The protein C pathway is an important regulator of the coagulation system and reduces the inflammatory response. The aim of the study was to examine the effects of recombinant human activated protein C (rhAPC) in the early phase of Pseudomonas aeruginosa (Pa)-induced lung injury. METHODS: The study was conducted in vivo on a rat model of Pa-induced ALI. Continuous intravenous (IV) rhAPC was administrated simultaneously with intratracheal (IT) Pa. We instilled into the airspaces a 5% bovine albumin solution with 1 μ(Ci of (125 )I-albumin and injected IV 1 μ(Ci of (111)In-albumin to measure lung liquid clearance (LLC) and endothelial injury. Cytokines levels (TNFα and IL-6) and thrombin-antithrombin (TAT) complexes were measured in blood and bronchoalveolar lavage fluid (BALF) at 4 hours. Four groups were compared: control (CTR), pneumonia (PNP) receiving IT Pa (0.5 ml/kg of 1 × 10(9 )cfu), APC: IV rhAPC (300 μg/kg/h), A-PNP: IT Pa /IV rhAPC. RESULTS: Alveolar-capillary permeability was increased in the PNP versus the CTR group (0.28 ± 0.08 vs. 0.03 ± 0.01, p < 0.05). IV rhAPC in Pa-induced ALI led to further injury (0.47 ± 0.17 vs. 0.28 ± 0.08, p = 0.2). The LLC was significantly decreased in the A-PNP group compared to PNP group (9.1 ± (4.3% vs. 33.4 ± 2.6%, p < 0.05). The lung wet to dry weight ratio was significantly increased in the PNP group (4.62 ± 0.31) compared to the CTR group (3.87 ± 0.22, p < 0.05). IV rhAPC administration tends to increase this parameter in Pa-induced ALI (5.80 ± 0.66, p = 0.07). These findings were associated with a loss of inflammatory response compartmentalization measured by TNFα and IL-6 systemic levels. TAT complexes in BALF were increased in the A-PNP group (23.17 ± 2.89 ng/ml) compared to the CTR group (0.92 ± 0.17 ng/ml, p < 0.05) and the PNP group (11.06 ± 2.76 ng/ml, p < 0.05). CONCLUSION: rhAPC reduces LLC following Pa-induced ALI and may influence pulmonary edema formation. The early massive fibrin formation is probably beneficial in ALI limiting both the extent of injury and permeability disorders.
format Text
id pubmed-1435891
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-14358912006-04-14 Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response Robriquet, Laurent Collet, François Tournoys, Antoine Prangère, Thierry Nevière, Rémi Fourrier, François Guery, Benoît P Respir Res Research BACKGROUND: Acute lung injury (ALI) induces a coagulation/fibrinolysis imbalance and leads to fibrin deposition. The protein C pathway is an important regulator of the coagulation system and reduces the inflammatory response. The aim of the study was to examine the effects of recombinant human activated protein C (rhAPC) in the early phase of Pseudomonas aeruginosa (Pa)-induced lung injury. METHODS: The study was conducted in vivo on a rat model of Pa-induced ALI. Continuous intravenous (IV) rhAPC was administrated simultaneously with intratracheal (IT) Pa. We instilled into the airspaces a 5% bovine albumin solution with 1 μ(Ci of (125 )I-albumin and injected IV 1 μ(Ci of (111)In-albumin to measure lung liquid clearance (LLC) and endothelial injury. Cytokines levels (TNFα and IL-6) and thrombin-antithrombin (TAT) complexes were measured in blood and bronchoalveolar lavage fluid (BALF) at 4 hours. Four groups were compared: control (CTR), pneumonia (PNP) receiving IT Pa (0.5 ml/kg of 1 × 10(9 )cfu), APC: IV rhAPC (300 μg/kg/h), A-PNP: IT Pa /IV rhAPC. RESULTS: Alveolar-capillary permeability was increased in the PNP versus the CTR group (0.28 ± 0.08 vs. 0.03 ± 0.01, p < 0.05). IV rhAPC in Pa-induced ALI led to further injury (0.47 ± 0.17 vs. 0.28 ± 0.08, p = 0.2). The LLC was significantly decreased in the A-PNP group compared to PNP group (9.1 ± (4.3% vs. 33.4 ± 2.6%, p < 0.05). The lung wet to dry weight ratio was significantly increased in the PNP group (4.62 ± 0.31) compared to the CTR group (3.87 ± 0.22, p < 0.05). IV rhAPC administration tends to increase this parameter in Pa-induced ALI (5.80 ± 0.66, p = 0.07). These findings were associated with a loss of inflammatory response compartmentalization measured by TNFα and IL-6 systemic levels. TAT complexes in BALF were increased in the A-PNP group (23.17 ± 2.89 ng/ml) compared to the CTR group (0.92 ± 0.17 ng/ml, p < 0.05) and the PNP group (11.06 ± 2.76 ng/ml, p < 0.05). CONCLUSION: rhAPC reduces LLC following Pa-induced ALI and may influence pulmonary edema formation. The early massive fibrin formation is probably beneficial in ALI limiting both the extent of injury and permeability disorders. BioMed Central 2006 2006-03-22 /pmc/articles/PMC1435891/ /pubmed/16553944 http://dx.doi.org/10.1186/1465-9921-7-41 Text en Copyright © 2006 Robriquet et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Robriquet, Laurent
Collet, François
Tournoys, Antoine
Prangère, Thierry
Nevière, Rémi
Fourrier, François
Guery, Benoît P
Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response
title Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response
title_full Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response
title_fullStr Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response
title_full_unstemmed Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response
title_short Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response
title_sort intravenous administration of activated protein c in pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1435891/
https://www.ncbi.nlm.nih.gov/pubmed/16553944
http://dx.doi.org/10.1186/1465-9921-7-41
work_keys_str_mv AT robriquetlaurent intravenousadministrationofactivatedproteincinpseudomonasinducedlunginjuryimpactonlungfluidbalanceandtheinflammatoryresponse
AT colletfrancois intravenousadministrationofactivatedproteincinpseudomonasinducedlunginjuryimpactonlungfluidbalanceandtheinflammatoryresponse
AT tournoysantoine intravenousadministrationofactivatedproteincinpseudomonasinducedlunginjuryimpactonlungfluidbalanceandtheinflammatoryresponse
AT prangerethierry intravenousadministrationofactivatedproteincinpseudomonasinducedlunginjuryimpactonlungfluidbalanceandtheinflammatoryresponse
AT neviereremi intravenousadministrationofactivatedproteincinpseudomonasinducedlunginjuryimpactonlungfluidbalanceandtheinflammatoryresponse
AT fourrierfrancois intravenousadministrationofactivatedproteincinpseudomonasinducedlunginjuryimpactonlungfluidbalanceandtheinflammatoryresponse
AT guerybenoitp intravenousadministrationofactivatedproteincinpseudomonasinducedlunginjuryimpactonlungfluidbalanceandtheinflammatoryresponse